MarketPeel
Insider Trading Intelligence
CG

Corey S. Goodman

ALXO
DIRECTOR · ALX ONCOLOGY HOLDINGS INC · CIK 0001278411
FILING MIX · LIFETIME67%/33%
BUYS
18
SELLS
9
TOTAL VALUE
$26.15M
COMPANIES
3
ACTIVE SINCE
Jul 2020
HOLDINGS NOW
9,309,931
AVG SELL PX
TRADE KIND
SHOWING 27 / 27
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by Corey S. Goodman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+100.00%+15.42%-1.06%+16.48%+7.13%
14d3+66.67%+17.64%-2.33%+19.97%+21.95%
30d3+66.67%+19.38%+1.23%+18.15%+31.84%
60d3+100.00%+14.85%-0.26%+15.11%+19.28%
90d3+66.67%+12.02%+4.82%+7.20%+8.65%
180d3(1 pending)+50.00%+63.15%+12.49%+50.66%+50.66%
1y3(1 pending)+50.00%+5.83%+25.07%-19.25%-19.25%
2y3(2 pending)+0.00%-61.07%+26.30%-87.37%-87.37%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ALXO · 8,453,038 shares · as of Feb 2, 2026
02,113,2604,226,5196,339,7798,453,038202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 18 buys / 9 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASE
3,184,713$1.57$5.00M8,453,038Feb 2, 2026Feb 4, 2026View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
40,40040,400Jan 20, 2026Jan 21, 2026View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
40,40040,400Jan 21, 2025Jan 23, 2025View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
SALE
214,6920Jul 22, 2024Jul 22, 2024View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
214,6921,058,284Jul 22, 2024Jul 22, 2024View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
416,666$12.00$5.00M1,936,637Jul 22, 2024Jul 22, 2024View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
SALE
843,5920Jul 22, 2024Jul 22, 2024View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
461,6871,519,971Jul 22, 2024Jul 22, 2024View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
843,592843,592Jul 22, 2024Jul 22, 2024View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
20,20020,200Jun 13, 2024Jun 14, 2024View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
20,20020,200Jun 20, 2023Jun 22, 2023View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
12,00412,004Jun 15, 2022Jun 16, 2022View →
VTYX
VENTYX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
13,30113,301Jun 9, 2022Jun 10, 2022View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
12,00412,004Jun 11, 2021Jun 15, 2021View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
3,100,0200Jul 21, 2020Jul 21, 2020View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
2,398,5880Jul 21, 2020Jul 21, 2020View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASE
3,941,9495,268,325Jul 21, 2020Jul 21, 2020View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASE
3,100,0203,969,789Jul 21, 2020Jul 21, 2020View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
15,7940Jul 21, 2020Jul 21, 2020View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
490,4110Jul 21, 2020Jul 21, 2020View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
1,052,9500Jul 21, 2020Jul 21, 2020View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
78,1750Jul 21, 2020Jul 21, 2020View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASE
52,64754,083Jul 21, 2020Jul 21, 2020View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
52,6470Jul 21, 2020Jul 21, 2020View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASE
93,969113,287Jul 21, 2020Jul 21, 2020View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASE
850,000$19.00$16.15M850,000Jul 21, 2020Jul 21, 2020View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
24,00924,009Jul 16, 2020Jul 17, 2020View →
Other insiders · ALXO
Loading peer insiders…
About this filer
CIK 0001278411
ROLE
Director
PRIMARY
ALXO
COMPANIES
3
ACTIVE SINCE
Jul 2020
MARKETPEEL · /INSIDER/0001278411DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback